The Multiple Potential Biomarkers for Predicting Immunotherapy Response—Finding the Needle in the Haystack
Tamiem Adam(Camden and Campbelltown Hospitals), Tara L. Roberts(Camden and Campbelltown Hospitals), Victoria Bray, Therese M. Becker(Liverpool Hospital), Wei Chua(Liverpool Hospital)
Cited by 25
Related Papers
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507
The mammalian PYHIN gene family: Phylogeny, evolution and expression
|BMC Evolutionary Biology|2012|202
The Molecular Basis for the Lack of Immunostimulatory Activity of Vertebrate DNA
|The Journal of Immunology|2003|174